Komori
Other Disclosures2395SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.Information and Communications, Services and Others

SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. and Kumamoto University Launch Collaborative Graduate School Program to Foster Practical Drug Discovery Talent Through Industry-Academia Collaboration

SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. and Kumamoto University have launched a collaborative graduate school program to train doctoral researchers in drug discovery. The program combines SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.'s research and development operations with Kumamoto University's educational and research capabilities to provide practical education and research supervision.

Worth reading
55In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

Drug Discovery Innovation Training Program
Applicable field (uses covered by this announcement)

Drug discovery research, pharmaceutical development, translational research, regulatory science, and nonclinical development research

Launch date1 October 2026 (already opened)
Contract Date1 July 2026
Relationship between the counterparty and the company
SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.2395
Relationship with the Company

The parties entered into an agreement concerning the collaborative graduate school program on 1 July 2026, establishing a relationship in which Kumamoto University and SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. jointly conduct education and research.

CounterpartyKumamoto University

Located in Kumamoto City, Kumamoto Prefecture; president: Ogawa Hisao (小川 久雄). A national university corporation with the Graduate School of Pharmaceutical Sciences' doctoral program in the Drug Discovery and Life Pharmaceutical Sciences major.

Location (as indicated in this announcement)

SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.'s research and development operations (the specific location is not identified in the document)

Impact on Business Performance

The document states that the parties aim to foster drug discovery professionals, strengthen SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.'s research and development capabilities, and contribute to enhancing Japan's drug discovery capabilities. No impact on sales or profit is quantified.

The company does not address Contract Value / Offering price.

Announced details
ItemDetails
Names of Products / Services CoveredDrug Discovery Innovation Training Program
CounterpartyKumamoto University
Counterparty overviewLocated in Kumamoto City, Kumamoto Prefecture; president: Ogawa Hisao (小川 久雄). A national university corporation with the Graduate School of Pharmaceutical Sciences' doctoral program in the Drug Discovery and Life Pharmaceutical Sciences major.
Relationship with the CompanyThe parties entered into an agreement concerning the collaborative graduate school program on 1 July 2026, establishing a relationship in which Kumamoto University and SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. jointly conduct education and research.
Contract Date1 July 2026
Launch date1 October 2026 (already opened)
Applicable areaDrug discovery research, pharmaceutical development, translational research, regulatory science, and nonclinical development research
LocationSHIN NIPPON BIOMEDICAL LABORATORIES,LTD.'s research and development operations (the specific location is not identified in the document)
Impact on Business PerformanceThe document states that the parties aim to foster drug discovery professionals, strengthen SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.'s research and development capabilities, and contribute to enhancing Japan's drug discovery capabilities. No impact on sales or profit is quantified.
Items this document does not state (9)
Contract ValueOffering priceAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historySource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The purpose is to create an environment where students can systematically and practically learn everything from drug discovery research through pharmaceutical development, thereby fostering highly skilled drug discovery professionals. The program is intended to integrate Kumamoto University's basic research and educational capabilities with SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.'s practical expertise, specialized personnel and research and development environment in pharmaceutical development.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. and Kumamoto University Launch Collaborative Graduate School Program to Foster Practical Drug Discovery Talent Through Industry-Academia Collaboration | SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. (2395) timely disclosure | Komori